AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Recruiting now · Phase 2
Conditions studied: Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
In brief
The purpose of this study is to assess the safety, tolerability, efficacy, pharmacokinetics (PK), and immunogenicity of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid tumours expressing CLDN18.2.
Key facts
- Study ID
- NCT06219941
- Run by
- AstraZeneca
- People needed
- 226
- Starts
- 2023-12-13
- Expected to finish
- 2027-06-28
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Kuala Lumpur, Malaysia (enrolling)
- Research Site — Kuching, Malaysia (enrolling)
- Research Site — Orange, California, United States (enrolling)
- Research Site — Palo Alto, California, United States (enrolling)
- Research Site — Kuala Selangor, Malaysia (enrolling)
- Research Site — Santa Rosa, California, United States (enrolling)
- Research Site — Louisville, Kentucky, United States (enrolling)
- Research Site — Murdoch, Australia (enrolling)
- Research Site — Randwick, Australia (enrolling)
- Research Site — Commack, New York, United States (enrolling)
- Research Site — Providence, Rhode Island, United States (enrolling)
- Research Site — Montreal, Quebec, Canada (enrolling)
- Research Site — Sherbrooke, Quebec, Canada (enrolling)
- Research Site — Houston, Texas, United States (enrolling)
- Research Site — Melbourne, Australia (enrolling)
- Research Site — Tbilisi, Georgia (enrolling)
- Research Site — Chūōku, Japan (enrolling)
- Research Site — Kashiwa, Japan (enrolling)
- Research Site — Kitaadachi-gun, Japan (enrolling)
- Research Site — Kōtoku, Japan (enrolling)
- Research Site — Nagoya, Japan (enrolling)
- Research Site — Osakasayama-shi, Japan (enrolling)
- Research Site — George Town, Malaysia (enrolling)
- Research Site — Toronto, Ontario, Canada (enrolling)
- Research Site — Chisinau, Moldova (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.